Mechanism of Action Considerations in the Management of IBS-C

Darren M. Brenner*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)749-756
Number of pages8
JournalGastroenterology and Hepatology
Volume19
Issue number12
StatePublished - Dec 2023

Funding

Dr Brenner is a speaker, advisor, and consultant and has participated in educational programs for American Gastroenterological Association (AGA), Anji Pharmaceuticals, Ardelyx, Inc., Continuing Education Alliance, LLC, Continuing Education Company, Inc., Elsevier, Inc., Enova International, Focus Medical Communications, LLC, GI Health Foundation, Gemelli Biotech, Ironwood Pharmaceuticals, Inc., Mahana Therapeutics, Inc., MedForce, Inc., Meetings & Events International, Pri-Med Institute, LLC, Primary Care Education Consortium, RedHill Biopharma Ltd, Salix Pharmaceuticals, Inc., Tactical Advantage Group, University of California, Los Angeles (UCLA), and WebMD, LLC.

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this